Showing 1 - 2 results of 2 for search 'Xunqiang Wang', query time: 0.01s Refine Results
  1. 1
    Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma

    Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma by Wenjiao Tang, Yan Li, Li Zhang, Xushu Zhong, Qiushi Liang, Yuhuan Zheng, Yuzhang Liu, Yafei Wang, Xunqiang Wang, Yun Zeng, Baijun Fang, Li Zheng, Ting Niu

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study

    Efficacy and safety of TQB2450 combined with anlotinib as maintenance therapy for LS-SCLC after definitive concurrent or sequential chemoradiotherapy: a prospective phase Ib study by Xiaoli Liu, Xiaoyan Yin, Lulu Zhuang, Junxu Wen, Zhonghui Wei, Wenxing Cui, Minghao Yu, Kaikai Zhao, Lanping Liu, Lingling Kong, Liyang Jiang, Xuquan Jing, Hui Zhu, Xunqiang Wang, Xinjun Dong, Jinming Yu, Xiangjiao Meng

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: